medline.ch Respirationstrakt Interstitielle Pneumopathien

	Prominence of IL6, IGF, TLR, and Bioenergetics Pathway Perturbation in Lung Tissues of Scleroderma Patients With Pulmonary Fibrosis. Front Immunol Renaud L, da Silveira WA, Takamura N, Hardiman G, Feghali-Bostwick C. PMID: 32210969 [PubMed - in process]
	[Treatment of complications and nonpharmacological management of idiopathic pulmonary fibrosis]. Pneumologe (Berl) Gläser S, Glöckl R, Bonella F. PMID: 32206051 [PubMed]
	Does Normal Saline Have Clinical Effects in Infants with Bronchiolitis?: Evidence-based Medicine Viewpoint. Indian Pediatr Mathew JL. PMID: 32198866 [PubMed - in process]
	Disease progression across the spectrum of idiopathic pulmonary fibrosis: A multicentre study. Respirology Sgalla G, Lo Greco E, Calvello M, Varone F, Iovene B, Cerri S, Donatelli P, Vancheri A, Pavone M, Luppi F, Vancheri C, Richeldi L. PMID: 32190952 [PubMed - as supplied by publisher]
	Biomarkers and their potential functions in idiopathic pulmonary fibrosis. Expert Rev Respir Med Ni S, Peng H, Song M, Guo W, Guo T, Shen Q. PMID: 32187497 [PubMed - as supplied by publisher]
	A pharmacological approach to study the active compounds in Jinshui Huanxian formula in treatment of pulmonary fibrosis. J Tradit Chin Med Bai Y, Zhao P, Wu M, Li J. PMID: 32186009 [PubMed - in process]
	The importance of interventional timing in the bleomycin model of pulmonary fibrosis. Eur Respir J Kolb P, Upagupta C, Vierhout M, Ayaub E, Bellaye PS, Gauldie J, Shimbori C, Inman M, Ask K, Kolb MRJ. PMID: 32165401 [PubMed - as supplied by publisher]
	Design and rationale of a multi-center, pragmatic, open-label randomized trial of antimicrobial therapy - the study of clinical efficacy of antimicrobial therapy strategy using pragmatic design in Idiopathic Pulmonary Fibrosis (CleanUP-IPF) clinical trial. Respir Res Anstrom KJ, Noth I, Flaherty KR, Edwards RH, Albright J, Baucom A, Brooks M, Clark AB, Clausen ES, Durheim MT, Kim DY, Kirchner J, Oldham JM, Snyder LD, Wilson AM, Wisniewski SR, Yow E, Martinez FJ, CleanUP-IPF Study Team.. PMID: 32164673 [PubMed - in process]
	Survey of Physician's Knowledge, Attitudes, and Practices Regarding Idiopathic Pulmonary Fibrosis in Turkey. Turk Thorac J Türkta, Okumu, Uzun O, Kumbasar ÖÖ, Alt, Bingöl Z, Börekçi , Cottin V, Müsellim B. PMID: 32163363 [PubMed]
	Guidelines of the Polish Respiratory Society for diagnosis and treatment of idiopathic pulmonary fibrosis. Adv Respir Med Piotrowski WJ, Bestry I, Bia, Boros PW, Grzanka P, Jassem E, Jastrz, Klimczak D, Langfort R, Lewandowska K, Majewski S, Martusewicz-Boros MM, Onisch K, Pu, Siemi, Sobiecka M, Szo, Wiatr E, Wilczy, Ziora D, Ku. PMID: 32153010 [PubMed - in process]
	Sex differences in blood pro-oxidant status and platelet activation in children admitted with respiratory syncytial virus bronchiolitis: a pilot study. Ital J Pediatr De Jacobis IT, Vona R, Straface E, Gambardella L, Ceglie G, de Gennaro F, Pontini I, Vittucci AC, Carè A, Cittadini C, Villani A, Pietraforte D. PMID: 32143677 [PubMed - in process]
	Risk factors for bronchiolitis hospitalization in infants: AÂ French nationwide retrospective cohort study over four consecutive seasons (2009-2013). PLoS One Fauroux B, Hascoët JM, Jarreau PH, Magny JF, Rozé JC, Saliba E, Schwarzinger M. PMID: 32142528 [PubMed - in process]
	Retrospective Study of Effect of Fine Particulate Matter on Acute Exacerbation of Patients with Idiopathic Pulmonary Fibrosis. Biomed Environ Sci Che CL, Dong FS, Li JL, Zhang CL, Liu L, Wu YH, Wang K, Qi H. PMID: 32131961 [PubMed - in process]
	A prospective study on the association of dose-volume histogram parameters with oesophagitis, radiation pneumonitis, radiation induced pulmonary fibrosis after receiving chemoradiation for NSCLC. Ann Oncol Bhowal S, Chatterjee K, Dey J. PMID: 32131226 [PubMed]
	Nasal Deformity in Granulomatosis with Polyangiitis. N Engl J Med Bello F, Fagni F. PMID: 32130816 [PubMed - indexed for MEDLINE]
	Azithromycin administered for acute bronchiolitis may have a protective effect on subsequent wheezing. J Bras Pneumol Luisi F, Roza CA, Silveira VD, Machado CC, Rosa KMD, Pitrez PM, Jones MH, Stein RT, Leitão LAA, Comaru T, Mocellin M, Pinto LA. PMID: 32130359 [PubMed - in process]
	Brazilian guidelines for the pharmacological treatment of idiopathic pulmonary fibrosis. Official document of the Brazilian Thoracic Association based on the GRADE methodology. J Bras Pneumol Baddini-Martinez J, Ferreira J, Tanni S, Alves LR, Cabral Junior BF, Carvalho CRR, Cezare TJ, Costa CHD, Gazzana MB, Jezler S, Kairalla RA, Kawano-Dourado L, Lima MS, Mancuzo E, Moreira MAC, Rodrigues MP, Rodrigues SCS, Rubin AS, Rufino RL, Steidle LJM, Storrer K, Baldi BG. PMID: 32130337 [PubMed - in process]
	Idiopathic Pulmonary Fibrosis (IPF) and pulmonary hypertension: Heracles meets the Hydra. Br J Pharmacol Rajagopal K, Bryant AJ, Sahay S, Wareing N, Zhou Y, Pandit LM, Karmouty-Quintana H. PMID: 32128790 [PubMed - as supplied by publisher]
	The efficacy of recombinant human soluble thrombomodulin (rhsTM) treatment for acute exacerbation of idiopathic pulmonary fibrosis: a systematic review and meta-analysis. BMC Pulm Med Kamiya H, Panlaqui OM. PMID: 32122329 [PubMed - in process]
	DROSHA-Dependent miRNA and AIM2 Inflammasome Activation in Idiopathic Pulmonary Fibrosis. Int J Mol Sci Cho SJ, Lee M, Stout-Delgado HW, Moon JS. PMID: 32121297 [PubMed - in process]

Artikel 1 - 20 / 25539

Seite 1 von 1277



		Zeitfenster

	Mediscope AG E-mail: info@mediscope.ch
	Disclaimer \| Datenschutzerklärung / Privacy Policy \| Werbung